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SUMMARY 
Cervical cancer ranks as the second most frequent cancer among women globally. The majority of patients 
present in advanced disease stages, leading to high mortality rates. Information on the survival of cervical 
cancer patients in Kenya is lacking which is necessary in estimating the burden of the disease and 
informing policy shifts in management of the disease. The objective of this study was to estimate the cure 
fraction, the survival time and rate and, identify covariates that significantly affect the survival of patients 
with cervical cancer in Nairobi, Kenya. A retrospective, descriptive non)intervention study of selected 
patients with cancer of the cervix was carried out in Nairobi, Kenya. 211 patients with an initial diagnosis of 
cancer of the cervix between January 2006 and June 2007 were followed up for five years respectively. 108 
(51.18%) of them were confirmed dead within that period, 15 (7.11%) were still alive and 88 (41.70%) were 
lost to follow up. Most of the patients were from low income areas (60.19%) within Nairobi, followed by 
those from middle income areas (37.91%) with the smallest proportion coming from high income areas 
(1.90%). The patients’ ages ranged from 14 to 76 years; the median mean age was 46 years while the mean 
was 46.45 years. The probability of surviving beyond the maximum amount of time (60 months) was 
estimated at 0.198 using the Kaplan)Meier estimator. The cumulative proportion surviving at the end of the 
study interval was 0.67 at stage I, 0.36 at stage II, 0.15 at stage III and 0 at stage IV. The median survival 
time at stage I is 60 months, 23.02 months at stage II, 10.14 months at stage III and 9.73 at stage IV. The 
Cox regression model was used to identify covariates that significantly affect the survival duration of 
cervical cancer patients. The age of patients, stage at diagnosis and level of education significantly affected 
the survival. Patients with an initial diagnosis at stage II, stage III and stage IV had an increased risk of 
death 6.29, 13.71 and 15.47 times respectively those at stage I. Therefore, early detection of cervical 
cancer and prompt treatment should be taken up to improve the overall survival of the patients. 
[Afr J Health Sci. 2013; 25:92103] 
Introduction 
Cancer of the cervix is a serious public health problem 
globally, especially in developing countries where it is 
the second most common cancer in women. Every 
year, approximately half a million new cases of cancer 
of the cervix are reported globally, 80% of which 
occurs in developing countries, where the disease is 
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also the leading cause of cancerrelated death among 
women [1]. The huge disparities in morbidity and 
mortality between developed and developing countries 
exist largely because over the last few decades, 
developed countries have implemented effective 
programmes for its prevention, in some countries 
reducing incidence and mortality by up to 80% [1, 2]. 
Most cervical cancer cases (99%) are linked to genital 
infection with human papillomavirus (HPV) especially 
type 16 or 18 [3]. HPV is a common sexually
transmitted virus that does not always cause 
symptomatic disease in infected individuals. Existing 
evidence indicates that more than 97% of all cancers 
of the cervix are associated with persistent infection of 
HPV. Cancer of the cervix is a disease with a long 
latent period [4, 5, 6]. In subSaharan Africa, the 
causes of high mortality rates are associated with 
poor access to medical facilities, poor nutrition, late 
presentation with the disease, poor quality care, low 
rate of followup, and women not completing 
treatment due to economic barriers. Cultural factors 
also play a role in the rates of cervical cancer 
including: early marriage, polygamous marriage, and 
high gender parity. These factors afflict women and 
girls living in rural areas at much greater rates [7].  
In Kenya, recent estimates indicate that every year 
2454 women are diagnosed with cervical cancer and 
1676 die of the disease. Cervical cancer ranks as the 
second most frequent cancer among women in 
Kenya. About 38.8% of women in the general 
population are estimated to harbour cervical HPV 
infection at a given time, and 60.9% of invasive 
cervical cancers are attributed to HPVs 16 or 18 [7].  
The survival of cancer patients is an important 
indicator of their prognosis. Currently, there are no 
survival studies that have been conducted on cervical 
cancer in Kenya, unlike in other parts of the world. 
This study therefore comes up with the findings on the 
five year survival rates and survival duration of 
patients with cervical cancer considering the initial 
stage of diagnosis and other covariates such as 
education level, age, smoking behaviour, alcohol 
intake, grade of cervical cancer, treatment given, 
residence and HIV status of patient. 
Methodology 
Study design 
A retrospective, descriptive nonintervention study 
was carried out in which cervical cancer cases 
diagnosed in January 2005 and June 2007 were 
followed up to January 2010 and June 2012 for five 
years respectively to determine an individual’s survival 
duration. It involved the use available information from 
medical records on cervical cancer patients and follow 
up of patients by contacting and interviewing the 
patients or their next of kin to determine the vital 
status of patients in case of missing on unclear details 
from available records. Follow up was also done using 
medical records at the Nairobi hospice for patients 
who had been referred there.  
Study site 
This study was conducted at Kenyatta National 
Hospital in Nairobi, Kenya. This facility was ideal for 
this study because it provides high quality and 
specialized cancer treatment and it has the capacity to 
handle all referrals in Kenya. This makes it a hospital 
of choice for a large proportion of cancer patients. 
Study population 
The study population were women who were residents 
of Nairobi, had a new diagnosis of cervical cancer 
between January 2005 and June 2007 and were 
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aged between 14 and 79 years. Women were 
excluded if they were aged beyond 80 years because 
the cure fraction is less reliable for this age group [8] 
or were diagnosed based on death certificate or 
autopsy. 
Sampling 
Using the WHO manual ‘Sample size determination in Health studies’ [9] the sample size was estimated as follows: 
Test survival rate                              50% 
Anticipated survival rate                      40% 
Level of significance ( )                      5% 
Power of the test ( )                          90% 
Confidence level ( )                           95% 
Using the formula 
  
For    and    the sample size is 211. 
The purposive sampling method was used. Criteria 
used were according to the explained inclusion and 
exclusion criteria. 
Data management and analysis 
Excel was used to capture data and produce some 
descriptive graphics. R version 2.15.1[10] and SPSS 
statistical software were used for statistical analysis. 
Survival analysis was performed using the Kaplan
Meier estimator. The Life Table was used to estimate 
both the cure fraction and the relative survival of 
patients. The logrank test was performed to compare 
the expected number of events at each stage of 
diagnosis against the observed values. The Cox 
Regression model was used to study the association 
between the survival with potential risk factors and 
other covariates. 
Results 
Description of the dataset 
211 patients with an initial diagnosis of cancer of the 
cervix between January, 2006 and June 2007 were 
followed up for five years respectively. 108 (51.18%) 
of them were confirmed dead within that period, 15 
(7.11%) were still alive and 88 (41.70%) were lost to 
follow up. The patients’ ages ranged from 14 to 76 
years; the median age was 46 years while the mean 
was 46.45 years.   53.08% of these patients were 





African Journal of Health Sciences, Volume 25, Number 2, AprilJune 2013 
 
Figure 1: Marital Status of patients 
 
In addition 49.76% and 47.39% of the patients had 
never engaged in cigarette smoking and alcohol 
intake respectively. Only 1.42% and 3.32% had a 
history of smoking and drinking alcohol respectively 
while the rest their drinking and alcohol intake 
behaviour could not be ascertained. 
The residential areas in Nairobi were classified as 
high, middle and low income areas [11]. 60.19% of 
the patients were from low income areas, 37.91% 
from middle income areas with the smallest proportion 
coming from high income areas (1.90%). 
The largest proportion of patients highest level of 
education attained was primary at 47.87% and the 
least having attained university education at 0.47% 
(Figure 2). 
 










There is evidence that most of the participants were 
not engaging in regular screening for cervical cancer; 
most of the cases were diagnosed at advanced 
stages that is as from stage II (Table 4) and most of 
them were also diagnosed histologically (Table 1). 
57.35% were diagnosed histologically and at the 
same time at late stages of the tumor that is as from 
stage II (Table 1). Most of the tumors were poorly 
differentiated (19.43%). The HIV status of most 
patients could not be ascertained from medical 
records of the patients which were heavily relied on to 
provide accurate information.  
    Table 1: Patients’ diagnostic details 
 Number of  patients     % patients   
Method of diagnosis 
    Histology 121   57.35 
    Cytology 48   22.75 
    Others 42  19.90 
Stage 
    Stage I 15   7.11 
    Stage II 50    23.70 
    Stage III 63    29.86 
    Stage IV 30    14.22 
    Unknown 50   25.12 
 
Grade 
    Well differentiated 14 6.64 
    Moderately  differentiated 38 18.01 
    Poorly differentiated 41 19.43 
   Undifferentiated/Anaplastic 10 14.22 
    Unknown 108 25.12 
HIV Status 
    Negative 48   22.7 
    Positive 25   11.8 
    Unknown 138   65.4 
Treatment 
The treatment given to individual patients indicate that 
46.45% of the patients were surgically treated, 
60.19% received external radiotherapy while only 
4.74% received Brachytherapy and 14.22% were 
given chemotherapy (Table 2). 
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The cumulative proportion that survived at the end of 
the study interval was 0.67 at stage I, 0.36 at stage 
II, 0.15 at stage III and 0 at stage IV (Table 3). The 
greatest number and proportion of terminal events 
occurred as from stage II.  
Table 3: Proportion surviving at the end of the Study Interval 
   Stage Proportion Surviving  
   Stage I 
   Stage II 
   Stage III 
   Stage IV 
   Unknown 
                 0.67 
                 0.36 
                 0.15 
                 0.00 
                 0.09 
Survival time  
Right censoring was done on observations that were 
either alive or lost to follow up. The probability of 
surviving beyond five years is estimated at 0.198 
using the KaplanMeier estimator. The survival curve, 
Figure 3 gives a visual representation of the survival 
trend. Drops in the survival curve occur whenever the 
                                             Frequency      Percent 
None / Unknown                         45               21.33 
S                                      36               17.06 
S+ EBR                                     46               21.80 
S + EBR + B                               2                0.95 
S + EBR + B + C                          3                1.42  
S + EBR + C                               11               5.21 
EBR                                           50              23.70 
EBR + C                                     10               4.74 
EBR + B + C                                3                1.42 
EBR + B                                     2                 0.95 
C                                              3                 1.42 
                                   
Key 
S – Surgery 
EBR  External Beam Radiation 
B  Brachytherapy (Internal Beam Radiation) 
C  Chemotherapy 
 
98 
African Journal of Health Sciences, Volume 25, Number 2, AprilJune 2013 
 
terminal event occurs to a patient. The survival curve 
describes the relationship between the probability of 
survival and time as inverse.  The red dotted line 
shows that at 10 months about 50% of patients were 
still alive (Figure 3). The Figure shows a sharp drop 
in the survival of patients within the first few 
(approximately 15) months, indicating that most of the 
patients experienced the event early. 
Figure 3: Survival curve 
































Comparing Survival with Stage as Strata 
Using the logrank test, the survival at different stages 
of diagnosis were significantly different (χ2 = 20, df=4, 
<0.05) indicating that the survival at different stages 
of diagnosis are significantly different as shown in 
Table 4.  




The median survival time of patients declined sharply with advancement in stages at initial diagnosis (Table 3). 
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      Median Time (Months) 
               
Stage       I 
Stage      II 
Stage     III 






                    
60.000 
23.023      
10.136 
  9.730 
  8.057 
 
 
The effects of covariates on the survival  
To check whether all the nine variables deserved to 
be included in the final Cox Proportional Hazards 
regression model, stepwise regression was used. The 
AIC was lowest when four covariates are removed 
that is grade, HIV status, Drinking behaviour and 
Smoking behaviour as shown in Table 6. They were 
therefore excluded in subsequent analysis. 
Table 6: Stepwise regression 
      Covariate                      Df                   AIC 
      none                                                922.04 
      Age                              1                 925.26 
      Education                    2                 926.12 
      Income zone                2                 927.85 
      Treatment                    10                 932.43 
      Stage                           4                 939.79 
 
After removing the variables that do not deserve to be 
in the model, Table 7 shows that the age of a patient, 
stage at initial diagnosis and level of education 
significantly affects the survival, and some treatment 
options also significantly affect the survival as well. 
Three treatment options which are S + EBR + B + C, 
S + EBR + C and EBR significantly affect the survival 
of patients . There is evidence of a steady 
increase in the risk of death with advancements in 
stage at initial diagnosis. Patients with an initial 
diagnosis at stage II, stage III and stage IV have an 
increased risk of death 6.29, 13.71 and 15.47 times 
respectively those at stage I. Patients who had 
attended school beyond primary school were at a 






African Journal of Health Sciences, Volume 25, Number 2, AprilJune 2013 
 





95 % CI 
LL 




    Age  
Level of education 
    None/Primary 
    Post primary education 
    Unknown education level 
Income zone    
    High income zone 
    Medium income zone 
    Low income zone 
Stage 
    Stage I 
    Stage II 
    Stage III 
    Stage IV 
    Unknown stage 
Treatment 
    None/Unknown 
    S 
    S+ EBR 
    S + EBR + B 
    S + EBR + B + C 
    S + EBR + C 
    EBR 
    EBR + C 
    EBR + B + C 
    EBR + B 















































































































This study has demonstrated that the probability of 
surviving beyond five years when a patient is 
diagnosed with cancer of the cervix is estimated at 
0.198 using the KaplanMeier estimator and the 
cumulative proportion surviving at the end of the study 
interval is 0.67 at stage I, 0.36 at stage II, 0.15 at 
stage III and 0 at stage IV. The median survival time 
at stage I is 60 months, 23.02 months at stage II, 
10.14 months at stage III and 9.73 at stage IV. A 
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similar study of 261 patients with cancer of the cervix 
registered by the Kampala populationbased cancer 
registry, Uganda, between 1995 and 1997 had overall 
observed and relative survival for 3 years was 52.4% 
and 59.9% respectively [12]. This indicates that the 
more than 50% of patients in Kampala survived 
beyond three years while in this study only 26.3% of 
patients survived beyond three years. 
According to the Cox regression model that was used 
in this study to identify covariates that significantly 
affect the survival of patients with cancer of the cervix; 
the age of patients, stage at diagnosis and level of 
education proved to be significant. Some treatment 
options also proved to significantly affect the survival 
of patients. Only 7.11% of patients were ascertained 
to have had a diagnosis at stage I which shows that 
most of the patients were diagnosed at advanced 
stages. Also among cases that were treated by 
radiotherapy in Nairobi between 1974 and 1979 
patients with an initial presentation at stage I was only 
7% [13]. Similar studies conducted in Africa show that 
the stage at diagnosis is mostly advanced; the case of 
Kampala, Uganda where they recorded 27.9% of 
patients with an initial diagnosis at stage I is more 
than three times the proportion in this study. This 
difference is attributed to high levels of health 
awareness and easy access to medical facilities in 
Kampala [12]. This explains why the survival is low. 
In another study stage proved to be the only covariate 
that influences the survival significantly [2].  
Stage is important in determining the nature of 
treatment; at KNH patients between stage I and III are 
given radiotherapy treatment while those at stage IV 
are given chemotherapy treatment.  Brachytherapy 
otherwise called internal beam radiation allows use of 
a higher total dose of radiation to treat a smaller area 
and in a shorter time than is possible with external 
beam radiation treatment. 60.67% of patients had an 
initial diagnosis between stage I and III and 60.19% 
were given external radiotherapy treatment. From an 
oncologist’s perspective at KNH, the amount of 
radiation therapy for curative cases should be about 
80 gray (Gy) but most patients receive about 50Gy. 
This is because most of the patients in this study 
were being referred to Mulago Hospital in Kampala, 
Uganda for brachytherapy but because most of them 
come from low income zones they could not afford it. 
60.19% of patients in this study received external 
radiotherapy while only 4.74% received 
Brachytherapy. In the Kampala study only one in four 
patients (16 out of 63) had received both external 
beam and internal radiation, almost half of the patients 
(30 out of 63) received radiotherapy treatment by 
external beam alone and nine cases by internal 
radiation alone [12].  
In another study the following variables were 
analyzed: age; tumor staging; histopathological type of 
tumor; level of education; skin color; and year of 
diagnosis in association with the survival using Cox 
proportional hazards regression model.  As for level of 
education, those with 11 years of schooling or more 
showed a significantly better survival [14]. On the 
other hand this study showed that patients who had 
attended school beyond primary school were at a 
reduced risk compared to those who attended 
none/primary education. 
Conclusion 
The findings of this research show that the survival of 
patients is poor compared to other studies carried out 
in Africa. Patients with distant metastasis have an 
increased risk of death compared to those with 
localized cancer of the cervix. Early detection of 
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cervical cancer through regular screening and prompt 
and comprehensive treatment should be taken up to 
improve the overall survival of the patients.  
Recommendations 
An integrated national patient record keeping system 
linking all the medical facilities should be put in place 
by the government. This will make it easier to 
estimate disease burden and also assess 
interventions. For statistical analysis, actual statistics 
would be available rather than the use of estimates 
and better projections can be made.  
Government intervention to reduce the burden of the 
cost of cancer treatment on the patients is very 
necessary. This is because as noted in this study 
cancer of the cervix affects mostly the poor who 
cannot afford cancer treatment. In most cases they 
are undertreated because they cannot meet the high 
costs associated with cancer treatment.  
Improved awareness is an integral part of controlling 
cervical cancer. This can be done by having health 
education on cervical cancer incorporated in the 
teaching curriculums just like it has been done for HIV 
/ AIDS, carrying out medical camps and community 
mobilization activities among other channels that can 
be used to make people aware. This will encourage 
women to attend regular screening therefore 
increasing chances of diagnosis at the precancerous 
stage which is 100% curable. As discovered in this 
study there have been cases of uptake of herbal 
therapy and seeking religious intervention and in turn 
ignoring prescribed medication; this has posed a great 
danger to the health of such patients who eventually 
go back to the hospitals when the situation is much 
worse. Therefore extensive and expansive awareness 
will reduce the high mortality associated with cancer 
of the cervix among women.  
Decentralizing cancer treatment will to cut down on 
cost of transportation and associated costs as many 
patients are referred to Kenyatta National Hospital 
(KNH) given there are only two referral hospitals in 
Kenya. The amount of time one has to wait before 
they undergo especially curative treatment will be 
reduced. Long queues are witnessed at the 
Radiotherapy unit at KNH which make the conditions 
of patients to worsen in this event.  
There is need for improved and more efficient 
equipment required in cancer treatment as the existing 
ones are greatly strained and some of them are 
archaic.  
Further research on the time to remission and relapse, 
and treatment should be carried out to give more 
insight into the burden of the disease and disease 
management.  
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